Morning Market Movers
April 22, 2014 at 09:43 AM EDT
Revance Therapeutics (NASDAQ: RVNC) shares gained 21.91% to $34.89 after the company reported positive results from the RT002 Phase 1/2 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.